Granite incorporated in Delaware as a C Corporation. The company is owned in equal shares by the three members of the management team.
Creatine Monohydrate . This is a dietary supplement commonly used by athletes to improve strength, endurance, and muscle mass. Creatine has become the most popular body building supplement in use today. It is sold in many forms through health food stores, drug stores, and discount chains. The leading producers of Creatine are in Europe, and only a few recently in the United States. The distribution system is complex, with manufacturers selling through a layered system. We have developed a Creatine-based drink which is one-of-a-kind. We hope to begin marketing the product in 2001. Sales potential is well over $1 million per year.
Kelate Cu . This is a specialty product used in cosmetics. It is distributed through Distributor A by special arrangement. Their largest customers are Estee Lauder and Revlon. We project sales of this product to be between $140,000 and $175,000 per year.
Melasyn 100 . This is a synthetic form of natural melanin. It is used as a pigment for vitiligo preparation and as a self tanning agent. It is water soluble, which makes it easy to formulate in cosmetic preparations. We are working with Customer A to supply this product to Distributor A. We project sales of $250,000 in 2001.
G-REZ DB . This is a specialty coating material used on industrial buffing pads. We developed the product at the request of the Customer C and sales can reach $300,000 in 2001.
Ion Exchange Resins . We provide a toll drying service for Customer D at a level of $35,000 per year. We feel this can increase substantially with additional equipment.
Recrystallized Flavoring Product A . This is a crude Flavor A extract. We purify the extract into an edible grade flavoring using our proprietary recrystallization process. It is then used in both food and tobacco industries. We teamed with Distributor B, the world’s largest distributor of Flavor A, to develop the process. Broker A is the broker. Estimated sales based on current demand levels are $75,000 in 2001.
We are a highly technical niche player with a specialized product line that is in great demand. Our target markets are the distributors who have established relationships with speciality products firms, textile chemical companies, and consumer products outlets. We are essentially the manufacturing arm for these distributors and can provide development services, as well as products for them.
Our market is divided into three segments:
Customer Profiles :
Market Analysis | |||||||
2000 | 2001 | 2002 | 2003 | 2004 | |||
Potential Customers | Growth | CAGR | |||||
Commercial | 10% | 75,000 | 52,500 | 57,750 | 63,525 | 69,878 | -1.75% |
Consumer | 22% | 125,000 | 152,500 | 186,050 | 226,981 | 276,917 | 22.00% |
Textile | 4% | 35,000 | 36,400 | 37,856 | 39,370 | 40,945 | 4.00% |
Total | 13.34% | 235,000 | 241,400 | 281,656 | 329,876 | 387,740 | 13.34% |
Consumer Market : This is potentially our biggest market for Creatine Monohydrate; it is limited only by our ability to produce. We have distributors who are begging for the product and we have back orders now, so it is only logical that we will devote most of our time meeting this demand. We look at the potential in this market as the basis for our growth.
Industrial Products : Here, we are selling both through distributors as well as direct to manufacturers. This is an untapped market and has been sustained by our reputation and ability to meet formulation criteria. We know that a marketing effort in this segment will produce sales that could quite possibly bring this segment to an equal level with the consumer market.
Textile Products : We have enough experience within this segment to know that once our manufacturing capability is up and running we could actually devote an entire marketing effort to this segment alone. Both our toll and custom manufacturing capability is strategically attractive to all textile manufacturers, including growing markets outside the U.S.
The chemical industry is characterized by a wide variety of companies ranging in size from the large companies such as DuPont and Monsanto to smaller specialty firms such as ours. The companies are generally organized by either end-use markets or product technology. In the past decade there has been a general trend in the industry to change emphasis from chemicals to biotechnology and pharmaceuticals. The cost of product development and the need to operate factories at high levels of capacity have caused chemical companies of every size to outsource parts of the chemical and manufacturing processes. This has created opportunities for smaller companies to create and occupy niches in development and contract manufacturing. The outsource industry providers occupy a market segment commonly identified as custom and toll manufacturers.
In the mainstream business, channels are critical to volume. Manufacturers and distributors with impact in the international chemical market desperately need speciality and toll manufacturers like us to meet the demand. There are many specialty manufacturers, all of whom seem to have carved out a specific niche of expertise, and upon whom these major manufacturers depend for products. In competition, it seems that the line is drawn at the level of quality performance. We have achieved that level and are recognized for a high standard of quality performance. Companies who would seem to be our competition have subcontracted production to us because they do not have the ability to supply that level of quality.
We have achieved another milestone in the industry by developing certain formulations which we estimate would cost another firm $450,000 to duplicate. The Creatine Monohydrate formulation and process is one of them. We have the only process in the world that can produce this supplement in liquid form. It is extremely important that we seize this opportunity and begin to exclusively market this product.
We address the market through three business segments: speciality products, textile chemicals, and consumer products. We are a highly technical niche player who has developed strong alliances with distributors who have powerful channel relationships but lack manufacturing or product development capabilities.
Our marketing strategy assumes that we will serve these distributors in three ways:
Our competitive edge is in the formulations and manufacturing processes we have developed for the production of the seven products in which we specialize. As detailed above, we are in an excellent position to capture a significant part of the $300 million Creatine Monohydrate market. We simply need to establish a marketing program and begin to promote our capability.
Our sales strategy is outlined below in three phases.
Our sales forecast assumes no significant change in costs or prices, which is a reasonable assumption for the past two years.
Our sales increased from 1997 to 1999. We anticipate a slight drop in 2000 due to financial constraints. All of these sales were without the benefit of a marketing program. We feel that with a good marketing program and adequate manufacturing facilities we can achieve substantially increased sales goals in 2001 and 2002. While this seems ambitious, we rely on our distributors’ projections and based on that, we know we will be able to literally sell to the production capacity of our manufacturing facilities.
Sales Forecast | |||
FY 2001 | FY 2002 | FY 2003 | |
Sales | |||
Row 1 | $2,217,375 | $2,653,800 | $3,450,000 |
Other | $0 | $0 | $0 |
Total Sales | $2,217,375 | $2,653,800 | $3,450,000 |
Direct Cost of Sales | FY 2001 | FY 2002 | FY 2003 |
Row 1 | $975,445 | $928,830 | $1,207,500 |
Other | $0 | $0 | $0 |
Subtotal Direct Cost of Sales | $975,445 | $928,830 | $1,207,500 |
The following table shows specific milestones, with responsibilities assigned, dates, and budgets. We are focusing, in this plan, on a few key milestones that can be accomplished. In addition, shortly following funding we will hire a vice president of marketing and two office personnel. Plant personnel will be added as equipment and facilities are operational.
Milestones | |||||
Milestone | Start Date | End Date | Budget | Manager | Department |
Business Plan | 10/16/2000 | 12/1/2000 | $2,000 | Pres | Total |
Presentation to Funding Source | 12/5/2000 | 2/15/2001 | $0 | Team | Total |
Stage One New Funding | 2/15/2001 | 2/30/2001 | $523,500 | Team | Total |
Location move and up-fit | 3/15/2001 | 3/30/2001 | $15,000 | VP | Manufacturing |
Equipment Acquisition | 4/10/2001 | 4/20/2000 | $350,000 | VP | Manufacturing |
Raw Materials | 4/20/2001 | 4/30/2001 | $90,000 | VP | Manufacturing |
Marketing and Promotion | 4/20/2001 | 12/1/2001 | $400,000 | Pres | Marketing |
Totals | $1,380,500 |
We have a strong management team that can boast of over 30 years experience in technical and management expertise. Each member has a specific contribution. The president and CEO has spent 20 years working in the chemical industry, and is adept at expanding companies that are well-grounded, but lacking in funding. The vice president of Granite is a specialist in consulting for small business on strategic planning and growth programs. And the final member of the team contributes expertise in start-ups among the pharmaceutical industry. Together, this team has a proven background of expertise and is more than capable of transforming Granite into a leading specialty chemical manufacturer.
Note: Names and resume information have been removed from this sample plan to protect proprietary and confidential information.
Our present plan is to immediately bring two people into the manufacturing operation, followed by an additional two or three throughout the next year. We need to begin looking for a capable marketing professional who has a background in chemical sales. We would like to bring that person on board mid 2001. Followed by one or two sales representatives with both interpersonal and telephone marketing skills. We will also employ support personnel as required.
Personnel Plan | |||
FY 2001 | FY 2002 | FY 2003 | |
Manufacturing | $214,026 | $220,000 | $230,000 |
Sales | $15,000 | $30,000 | $80,000 |
Total People | 11 | 11 | 14 |
Total Payroll | $229,026 | $250,000 | $310,000 |
We plan to support our growth and debt obligations through increased sales and cash flow. Our major debt with Wachovia Bank is secured by personal and company collateral. Our financials do not include our estimate of the value of proprietary chemical formulations, nor the value of assignable customer contracts.
Positive The assumptions that support our projections in these tables are: The move to larger facilities and the additional equipment will result in increased production; and the back orders and new orders will be shipped. We have excellent agreements with our primary sources of supply and assume there will be no change in these relationships.We also assume that the demand for Creatine and our other products will continue to increase as evidenced in our market research.
Negative Another company could develop some of the formulations we have, in which case we would lose some of the technical and market advantage we now have. This will also decrease our valuation. If we cannot find a capable marketing person, who is both sales and technically savvy, in time to get into this market, we would be at a disadvantage. Our hope is that whomever takes an equity position in this project will add marketing expertise. Technology changes, as do buying habits and social structure. A major change in any one of these areas can have a detrimental effect on our business.
General Assumptions | |||
FY 2001 | FY 2002 | FY 2003 | |
Plan Month | 1 | 2 | 3 |
Current Interest Rate | 10.00% | 10.00% | 10.00% |
Long-term Interest Rate | 10.00% | 10.00% | 10.00% |
Tax Rate | 25.00% | 25.00% | 25.00% |
Other | 0 | 0 | 0 |
Our Break-even Analysis is based on running costs, the “burn rate” costs we incur to keep the business running, not on theoretical fixed costs that would be relevant only if we were closing. Between payroll, rent, utilities, and other basic day to day costs, we think the monthly figure shown below is a good estimate of fixed costs. Our average variable costs are shown as well. Our COS will be approximately 44% of sales, and we anticipate a healthy profit margin before taxes and debt service in 2001, increasing in 2002.
Our assumptions in average unit sales and average cost per kilogram depend on averaging. We do not really need to calculate an exact average because this is sufficiently close to help us to understand what the real break-even point will be.
Break-even Analysis | |
Monthly Revenue Break-even | $68,486 |
Assumptions: | |
Average Percent Variable Cost | 44% |
Estimated Monthly Fixed Cost | $38,358 |
Our profit projection before taxes or debt service for 2001 is attainable. In 2002, we anticipate an increase in net profit, and in 2003 as well.
Pro Forma Profit and Loss | |||
FY 2001 | FY 2002 | FY 2003 | |
Sales | $2,217,375 | $2,653,800 | $3,450,000 |
Direct Cost of Sales | $975,445 | $928,830 | $1,207,500 |
Other | $0 | $0 | $0 |
Total Cost of Sales | $975,445 | $928,830 | $1,207,500 |
Gross Margin | $1,241,930 | $1,724,970 | $2,242,500 |
Gross Margin % | 56.01% | 65.00% | 65.00% |
Expenses | |||
Payroll | $229,026 | $250,000 | $310,000 |
Sales and Marketing and Other Expenses | $104,800 | $104,000 | $29,000 |
Depreciation | $36,000 | $36,000 | $36,000 |
Leased Equipment | $11,172 | $25,000 | $25,000 |
Utilities | $12,000 | $15,000 | $18,000 |
Insurance | $3,545 | $5,000 | $0 |
Rent | $29,400 | $30,000 | $30,000 |
Payroll Taxes | $34,354 | $37,500 | $46,500 |
Other | $0 | $0 | $0 |
Total Operating Expenses | $460,297 | $502,500 | $494,500 |
Profit Before Interest and Taxes | $781,633 | $1,222,470 | $1,748,000 |
EBITDA | $817,633 | $1,258,470 | $1,784,000 |
Interest Expense | $34,739 | $37,855 | $41,455 |
Taxes Incurred | $186,723 | $296,154 | $426,636 |
Net Profit | $560,170 | $888,461 | $1,279,909 |
Net Profit/Sales | 25.26% | 33.48% | 37.10% |
Our cash position at the present time is negligible due to financial constraints in maintaining production for existing orders and being unable to expand to meet future demand. We expect to manage cash flow over the next three years with a couple infusions of new equity investment. We feel that, with the accompanying increases in accounts receivable and inventory, we can extend our line of short term credit. Because of our toll manufacturing capability, inventory can be maintained at a fairly constant level. Receivables, however, will increase dramatically in 2001, and possibly double by 2003.
Pro Forma Cash Flow | |||
FY 2001 | FY 2002 | FY 2003 | |
Cash Received | |||
Cash from Operations | |||
Cash Sales | $221,738 | $265,380 | $345,000 |
Cash from Receivables | $1,530,100 | $2,293,742 | $2,932,272 |
Subtotal Cash from Operations | $1,751,837 | $2,559,122 | $3,277,272 |
Additional Cash Received | |||
Sales Tax, VAT, HST/GST Received | $0 | $0 | $0 |
New Current Borrowing | $0 | $0 | $0 |
New Other Liabilities (interest-free) | $7,500 | $0 | $0 |
New Long-term Liabilities | $60,000 | $60,000 | $60,000 |
Sales of Other Current Assets | $0 | $0 | $0 |
Sales of Long-term Assets | $0 | $0 | $0 |
New Investment Received | $875,000 | $425,000 | $0 |
Subtotal Cash Received | $2,694,337 | $3,044,122 | $3,337,272 |
Expenditures | FY 2001 | FY 2002 | FY 2003 |
Expenditures from Operations | |||
Cash Spending | $229,026 | $250,000 | $310,000 |
Bill Payments | $1,364,802 | $1,515,967 | $1,829,035 |
Subtotal Spent on Operations | $1,593,828 | $1,765,967 | $2,139,035 |
Additional Cash Spent | |||
Sales Tax, VAT, HST/GST Paid Out | $0 | $0 | $0 |
Principal Repayment of Current Borrowing | $7,291 | $0 | $0 |
Other Liabilities Principal Repayment | $9,000 | $12,000 | $12,000 |
Long-term Liabilities Principal Repayment | $24,000 | $24,000 | $24,000 |
Purchase Other Current Assets | $45,000 | $35,000 | $35,000 |
Purchase Long-term Assets | $50,000 | $25,000 | $25,000 |
Dividends | $0 | $0 | $0 |
Subtotal Cash Spent | $1,729,119 | $1,861,967 | $2,235,035 |
Net Cash Flow | $965,218 | $1,182,155 | $1,102,237 |
Cash Balance | $977,218 | $2,159,373 | $3,261,611 |
Pro Forma Balance Sheet | |||
FY 2001 | FY 2002 | FY 2003 | |
Assets | |||
Current Assets | |||
Cash | $977,218 | $2,159,373 | $3,261,611 |
Accounts Receivable | $481,038 | $575,716 | $748,444 |
Inventory | $128,852 | $122,694 | $159,505 |
Other Current Assets | $45,000 | $80,000 | $115,000 |
Total Current Assets | $1,632,108 | $2,937,784 | $4,284,560 |
Long-term Assets | |||
Long-term Assets | $199,118 | $224,118 | $249,118 |
Accumulated Depreciation | $59,605 | $95,605 | $131,605 |
Total Long-term Assets | $139,513 | $128,513 | $117,513 |
Total Assets | $1,771,621 | $3,066,297 | $4,402,073 |
Liabilities and Capital | FY 2001 | FY 2002 | FY 2003 |
Current Liabilities | |||
Accounts Payable | $163,869 | $121,083 | $152,951 |
Current Borrowing | $0 | $0 | $0 |
Other Current Liabilities | $42,003 | $30,003 | $18,003 |
Subtotal Current Liabilities | $205,872 | $151,086 | $170,954 |
Long-term Liabilities | $360,550 | $396,550 | $432,550 |
Total Liabilities | $566,422 | $547,636 | $603,504 |
Paid-in Capital | $1,689,820 | $2,114,820 | $2,114,820 |
Retained Earnings | ($1,044,791) | ($484,621) | $403,840 |
Earnings | $560,170 | $888,461 | $1,279,909 |
Total Capital | $1,205,199 | $2,518,660 | $3,798,569 |
Total Liabilities and Capital | $1,771,621 | $3,066,297 | $4,402,073 |
Net Worth | $1,205,199 | $2,518,660 | $3,798,569 |
The following table outlines some of the more important ratios from the Chemical Products and Preparations manufacturing industry. The final column, Industry Profile, details specific ratios based on the industry as it is classified by the NAICS code, 325998.
Ratio Analysis | ||||
FY 2001 | FY 2002 | FY 2003 | Industry Profile | |
Sales Growth | 955.38% | 19.68% | 30.00% | 9.54% |
Percent of Total Assets | ||||
Accounts Receivable | 27.15% | 18.78% | 17.00% | 32.42% |
Inventory | 7.27% | 4.00% | 3.62% | 17.28% |
Other Current Assets | 2.54% | 2.61% | 2.61% | 38.61% |
Total Current Assets | 92.13% | 95.81% | 97.33% | 88.31% |
Long-term Assets | 7.87% | 4.19% | 2.67% | 11.69% |
Total Assets | 100.00% | 100.00% | 100.00% | 100.00% |
Current Liabilities | 11.62% | 4.93% | 3.88% | 24.17% |
Long-term Liabilities | 20.35% | 12.93% | 9.83% | 30.99% |
Total Liabilities | 31.97% | 17.86% | 13.71% | 55.16% |
Net Worth | 68.03% | 82.14% | 86.29% | 44.84% |
Percent of Sales | ||||
Sales | 100.00% | 100.00% | 100.00% | 100.00% |
Gross Margin | 56.01% | 65.00% | 65.00% | 23.42% |
Selling, General & Administrative Expenses | 39.81% | 40.16% | 26.99% | 10.99% |
Advertising Expenses | 3.38% | 2.83% | 0.00% | 0.13% |
Profit Before Interest and Taxes | 35.25% | 46.06% | 50.67% | 4.87% |
Main Ratios | ||||
Current | 7.93 | 19.44 | 25.06 | 2.71 |
Quick | 7.30 | 18.63 | 24.13 | 1.81 |
Total Debt to Total Assets | 31.97% | 17.86% | 13.71% | 67.53% |
Pre-tax Return on Net Worth | 61.97% | 47.03% | 44.93% | 4.59% |
Pre-tax Return on Assets | 42.16% | 38.63% | 38.77% | 14.15% |
Additional Ratios | FY 2001 | FY 2002 | FY 2003 | |
Net Profit Margin | 25.26% | 33.48% | 37.10% | n.a |
Return on Equity | 46.48% | 35.28% | 33.69% | n.a |
Activity Ratios | ||||
Accounts Receivable Turnover | 4.15 | 4.15 | 4.15 | n.a |
Collection Days | 56 | 81 | 78 | n.a |
Inventory Turnover | 10.91 | 7.38 | 8.56 | n.a |
Accounts Payable Turnover | 9.17 | 12.17 | 12.17 | n.a |
Payment Days | 28 | 35 | 27 | n.a |
Total Asset Turnover | 1.25 | 0.87 | 0.78 | n.a |
Debt Ratios | ||||
Debt to Net Worth | 0.47 | 0.22 | 0.16 | n.a |
Current Liab. to Liab. | 0.36 | 0.28 | 0.28 | n.a |
Liquidity Ratios | ||||
Net Working Capital | $1,426,236 | $2,786,697 | $4,113,606 | n.a |
Interest Coverage | 22.50 | 32.29 | 42.17 | n.a |
Additional Ratios | ||||
Assets to Sales | 0.80 | 1.16 | 1.28 | n.a |
Current Debt/Total Assets | 12% | 5% | 4% | n.a |
Acid Test | 4.97 | 14.82 | 19.75 | n.a |
Sales/Net Worth | 1.84 | 1.05 | 0.91 | n.a |
Dividend Payout | 0.00 | 0.00 | 0.00 | n.a |
Sales Forecast | |||||||||||||
Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | ||
Sales | |||||||||||||
Row 1 | 0% | $69,525 | $99,100 | $125,175 | $146,450 | $164,425 | $188,600 | $201,650 | $214,600 | $222,150 | $242,400 | $264,400 | $278,900 |
Other | 0% | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Total Sales | $69,525 | $99,100 | $125,175 | $146,450 | $164,425 | $188,600 | $201,650 | $214,600 | $222,150 | $242,400 | $264,400 | $278,900 | |
Direct Cost of Sales | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | |
Row 1 | $29,200 | $44,595 | $52,573 | $65,902 | $75,635 | $90,528 | $96,792 | $92,278 | $95,524 | $104,232 | $111,048 | $117,138 | |
Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
Subtotal Direct Cost of Sales | $29,200 | $44,595 | $52,573 | $65,902 | $75,635 | $90,528 | $96,792 | $92,278 | $95,524 | $104,232 | $111,048 | $117,138 |
Personnel Plan | |||||||||||||
Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | ||
Manufacturing | 0% | $13,282 | $13,282 | $13,282 | $15,760 | $18,920 | $18,920 | $18,920 | $19,500 | $19,500 | $19,500 | $21,580 | $21,580 |
Sales | 0% | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $15,000 |
Total People | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 11 | |
Total Payroll | $13,282 | $13,282 | $13,282 | $15,760 | $18,920 | $18,920 | $18,920 | $19,500 | $19,500 | $19,500 | $21,580 | $36,580 |
General Assumptions | |||||||||||||
Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | ||
Plan Month | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
Current Interest Rate | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | |
Long-term Interest Rate | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | |
Tax Rate | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | |
Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Pro Forma Profit and Loss | |||||||||||||
Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | ||
Sales | $69,525 | $99,100 | $125,175 | $146,450 | $164,425 | $188,600 | $201,650 | $214,600 | $222,150 | $242,400 | $264,400 | $278,900 | |
Direct Cost of Sales | $29,200 | $44,595 | $52,573 | $65,902 | $75,635 | $90,528 | $96,792 | $92,278 | $95,524 | $104,232 | $111,048 | $117,138 | |
Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
Total Cost of Sales | $29,200 | $44,595 | $52,573 | $65,902 | $75,635 | $90,528 | $96,792 | $92,278 | $95,524 | $104,232 | $111,048 | $117,138 | |
Gross Margin | $40,325 | $54,505 | $72,602 | $80,548 | $88,790 | $98,072 | $104,858 | $122,322 | $126,626 | $138,168 | $153,352 | $161,762 | |
Gross Margin % | 58.00% | 55.00% | 58.00% | 55.00% | 54.00% | 52.00% | 52.00% | 57.00% | 57.00% | 57.00% | 58.00% | 58.00% | |
Expenses | |||||||||||||
Payroll | $13,282 | $13,282 | $13,282 | $15,760 | $18,920 | $18,920 | $18,920 | $19,500 | $19,500 | $19,500 | $21,580 | $36,580 | |
Sales and Marketing and Other Expenses | $1,400 | $1,400 | $2,000 | $2,500 | $4,000 | $1,500 | $2,000 | $1,500 | $27,000 | $27,500 | $27,000 | $7,000 | |
Depreciation | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | |
Leased Equipment | $931 | $931 | $931 | $931 | $931 | $931 | $931 | $931 | $931 | $931 | $931 | $931 | |
Utilities | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | |
Insurance | $285 | $285 | $285 | $285 | $285 | $285 | $285 | $310 | $310 | $310 | $310 | $310 | |
Rent | $2,450 | $2,450 | $2,450 | $2,450 | $2,450 | $2,450 | $2,450 | $2,450 | $2,450 | $2,450 | $2,450 | $2,450 | |
Payroll Taxes | 15% | $1,992 | $1,992 | $1,992 | $2,364 | $2,838 | $2,838 | $2,838 | $2,925 | $2,925 | $2,925 | $3,237 | $5,487 |
Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
Total Operating Expenses | $24,340 | $24,340 | $24,940 | $28,290 | $33,424 | $30,924 | $31,424 | $31,616 | $57,116 | $57,616 | $59,508 | $56,758 | |
Profit Before Interest and Taxes | $15,985 | $30,165 | $47,662 | $52,258 | $55,366 | $67,148 | $73,434 | $90,706 | $69,510 | $80,552 | $93,844 | $105,004 | |
EBITDA | $18,985 | $33,165 | $50,662 | $55,258 | $58,366 | $70,148 | $76,434 | $93,706 | $72,510 | $83,552 | $96,844 | $108,004 | |
Interest Expense | $2,785 | $2,805 | $2,825 | $2,845 | $2,865 | $2,885 | $2,905 | $2,925 | $2,945 | $2,965 | $2,985 | $3,005 | |
Taxes Incurred | $3,300 | $6,840 | $11,209 | $12,353 | $13,125 | $16,066 | $17,632 | $21,945 | $16,641 | $19,397 | $22,715 | $25,500 | |
Net Profit | $9,900 | $20,520 | $33,627 | $37,060 | $39,376 | $48,197 | $52,897 | $65,836 | $49,924 | $58,190 | $68,144 | $76,500 | |
Net Profit/Sales | 14.24% | 20.71% | 26.86% | 25.31% | 23.95% | 25.56% | 26.23% | 30.68% | 22.47% | 24.01% | 25.77% | 27.43% |
Pro Forma Cash Flow | |||||||||||||
Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | ||
Cash Received | |||||||||||||
Cash from Operations | |||||||||||||
Cash Sales | $6,953 | $9,910 | $12,518 | $14,645 | $16,443 | $18,860 | $20,165 | $21,460 | $22,215 | $24,240 | $26,440 | $27,890 | |
Cash from Receivables | $7,750 | $9,836 | $63,460 | $89,972 | $113,296 | $132,344 | $148,708 | $170,132 | $181,874 | $193,367 | $200,543 | $218,820 | |
Subtotal Cash from Operations | $14,703 | $19,746 | $75,977 | $104,617 | $129,738 | $151,204 | $168,873 | $191,592 | $204,089 | $217,607 | $226,983 | $246,710 | |
Additional Cash Received | |||||||||||||
Sales Tax, VAT, HST/GST Received | 0.00% | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
New Current Borrowing | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
New Other Liabilities (interest-free) | $3,000 | $2,500 | $2,000 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
New Long-term Liabilities | $5,000 | $5,000 | $5,000 | $5,000 | $5,000 | $5,000 | $5,000 | $5,000 | $5,000 | $5,000 | $5,000 | $5,000 | |
Sales of Other Current Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
Sales of Long-term Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
New Investment Received | $75,000 | $0 | $0 | $300,000 | $0 | $0 | $0 | $500,000 | $0 | $0 | $0 | $0 | |
Subtotal Cash Received | $97,703 | $27,246 | $82,977 | $409,617 | $134,738 | $156,204 | $173,873 | $696,592 | $209,089 | $222,607 | $231,983 | $251,710 | |
Expenditures | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | |
Expenditures from Operations | |||||||||||||
Cash Spending | $13,282 | $13,282 | $13,282 | $15,760 | $18,920 | $18,920 | $18,920 | $19,500 | $19,500 | $19,500 | $21,580 | $36,580 | |
Bill Payments | $28,399 | $57,345 | $79,393 | $84,750 | $105,577 | $114,537 | $134,827 | $133,309 | $122,365 | $153,896 | $171,551 | $178,851 | |
Subtotal Spent on Operations | $41,681 | $70,627 | $92,675 | $100,510 | $124,497 | $133,457 | $153,747 | $152,809 | $141,865 | $173,396 | $193,131 | $215,431 | |
Additional Cash Spent | |||||||||||||
Sales Tax, VAT, HST/GST Paid Out | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
Principal Repayment of Current Borrowing | $607 | $607 | $607 | $607 | $607 | $607 | $607 | $607 | $607 | $607 | $607 | $614 | |
Other Liabilities Principal Repayment | $0 | $0 | $0 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | |
Long-term Liabilities Principal Repayment | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | |
Purchase Other Current Assets | $0 | $0 | $5,000 | $5,000 | $5,000 | $5,000 | $5,000 | $5,000 | $5,000 | $5,000 | $5,000 | $0 | |
Purchase Long-term Assets | $0 | $0 | $0 | $10,000 | $10,000 | $10,000 | $10,000 | $10,000 | $0 | $0 | $0 | $0 | |
Dividends | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
Subtotal Cash Spent | $44,288 | $73,234 | $100,282 | $119,117 | $143,104 | $152,064 | $172,354 | $171,416 | $150,472 | $182,003 | $201,738 | $219,045 | |
Net Cash Flow | $53,414 | ($45,988) | ($17,305) | $290,500 | ($8,366) | $4,141 | $1,519 | $525,175 | $58,616 | $40,603 | $30,244 | $32,665 | |
Cash Balance | $65,414 | $19,426 | $2,121 | $292,621 | $284,256 | $288,396 | $289,915 | $815,090 | $873,706 | $914,309 | $944,554 | $977,218 |
Pro Forma Balance Sheet | |||||||||||||
Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | ||
Assets | Starting Balances | ||||||||||||
Current Assets | |||||||||||||
Cash | $12,000 | $65,414 | $19,426 | $2,121 | $292,621 | $284,256 | $288,396 | $289,915 | $815,090 | $873,706 | $914,309 | $944,554 | $977,218 |
Accounts Receivable | $15,500 | $70,323 | $149,677 | $198,875 | $240,707 | $275,394 | $312,790 | $345,567 | $368,576 | $386,637 | $411,431 | $448,848 | $481,038 |
Inventory | $18,873 | $32,120 | $49,055 | $57,830 | $72,492 | $83,199 | $99,581 | $106,471 | $101,506 | $105,076 | $114,655 | $122,153 | $128,852 |
Other Current Assets | $0 | $0 | $0 | $5,000 | $10,000 | $15,000 | $20,000 | $25,000 | $30,000 | $35,000 | $40,000 | $45,000 | $45,000 |
Total Current Assets | $46,373 | $167,857 | $218,157 | $263,826 | $615,821 | $657,848 | $720,767 | $766,953 | $1,315,171 | $1,400,420 | $1,480,395 | $1,560,554 | $1,632,108 |
Long-term Assets | |||||||||||||
Long-term Assets | $149,118 | $149,118 | $149,118 | $149,118 | $159,118 | $169,118 | $179,118 | $189,118 | $199,118 | $199,118 | $199,118 | $199,118 | $199,118 |
Accumulated Depreciation | $23,605 | $26,605 | $29,605 | $32,605 | $35,605 | $38,605 | $41,605 | $44,605 | $47,605 | $50,605 | $53,605 | $56,605 | $59,605 |
Total Long-term Assets | $125,513 | $122,513 | $119,513 | $116,513 | $123,513 | $130,513 | $137,513 | $144,513 | $151,513 | $148,513 | $145,513 | $142,513 | $139,513 |
Total Assets | $171,886 | $290,370 | $337,670 | $380,339 | $739,334 | $788,361 | $858,280 | $911,466 | $1,466,684 | $1,548,933 | $1,625,908 | $1,703,067 | $1,771,621 |
Liabilities and Capital | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | |
Current Liabilities | |||||||||||||
Accounts Payable | $26,513 | $54,704 | $76,592 | $81,240 | $101,782 | $110,041 | $130,370 | $129,266 | $117,255 | $148,187 | $165,579 | $173,201 | $163,869 |
Current Borrowing | $7,291 | $6,684 | $6,077 | $5,470 | $4,863 | $4,256 | $3,649 | $3,042 | $2,435 | $1,828 | $1,221 | $614 | $0 |
Other Current Liabilities | $43,503 | $46,503 | $49,003 | $51,003 | $50,003 | $49,003 | $48,003 | $47,003 | $46,003 | $45,003 | $44,003 | $43,003 | $42,003 |
Subtotal Current Liabilities | $77,307 | $107,891 | $131,672 | $137,713 | $156,648 | $163,300 | $182,022 | $179,311 | $165,693 | $195,018 | $210,803 | $216,818 | $205,872 |
Long-term Liabilities | $324,550 | $327,550 | $330,550 | $333,550 | $336,550 | $339,550 | $342,550 | $345,550 | $348,550 | $351,550 | $354,550 | $357,550 | $360,550 |
Total Liabilities | $401,857 | $435,441 | $462,222 | $471,263 | $493,198 | $502,850 | $524,572 | $524,861 | $514,243 | $546,568 | $565,353 | $574,368 | $566,422 |
Paid-in Capital | $814,820 | $889,820 | $889,820 | $889,820 | $1,189,820 | $1,189,820 | $1,189,820 | $1,189,820 | $1,689,820 | $1,689,820 | $1,689,820 | $1,689,820 | $1,689,820 |
Retained Earnings | ($877,599) | ($1,044,791) | ($1,044,791) | ($1,044,791) | ($1,044,791) | ($1,044,791) | ($1,044,791) | ($1,044,791) | ($1,044,791) | ($1,044,791) | ($1,044,791) | ($1,044,791) | ($1,044,791) |
Earnings | ($167,192) | $9,900 | $30,419 | $64,047 | $101,106 | $140,482 | $188,679 | $241,576 | $307,412 | $357,336 | $415,526 | $483,671 | $560,170 |
Total Capital | ($229,971) | ($145,071) | ($124,552) | ($90,924) | $246,135 | $285,511 | $333,708 | $386,605 | $952,441 | $1,002,365 | $1,060,555 | $1,128,700 | $1,205,199 |
Total Liabilities and Capital | $171,886 | $290,370 | $337,670 | $380,339 | $739,334 | $788,361 | $858,280 | $911,466 | $1,466,684 | $1,548,933 | $1,625,908 | $1,703,067 | $1,771,621 |
Net Worth | ($229,971) | ($145,071) | ($124,552) | ($90,924) | $246,135 | $285,511 | $333,708 | $386,605 | $952,441 | $1,002,365 | $1,060,555 | $1,128,700 | $1,205,199 |
Fill-in-the-blanks and automatic financials make it easy.
No thanks, I prefer writing 40-page documents.
Discover the world’s #1 plan building software
By: Author Tony Martins Ajaero
Home » Business ideas » Chemical Industry
Are you about starting a chemical laboratory? If YES, here is a complete sample chemical laboratory business plan template & feasibility report you can use for FREE .
Okay, so we have considered all the requirements for starting a chemical laboratory. We also took it further by analyzing and drafting a sample chemical laboratory marketing plan template backed up by actionable guerrilla marketing ideas for chemical laboratories. So let’s proceed to the business planning section.
If you are a scientist and you intend starting your own business, you can decide to start your own chemical laboratory; it is an industry that is open to creative scientists.
Starting a chemical laboratory requires training, experience, creativity, reasonable startup capital, license and detailed business plan. The truth is that you can’t just wake up and launch your own chemical laboratory; you must follow established protocols. This industry is highly regulated because of the risks involved.
If you are sure this type of business is what you want to do after you must have conducted your research, then the next step to follow is to write a good business plan; a detailed blue print of how you intend raising your seed capital, setting up the business, managing the flow of the business, sorting out tax and marketing your products.
The truth is that it is one thing to have a fantastic idea cum business plan, but it is another thing for the business plan to translate to money/profits, that is why it is important to assemble a team of experts to work with if you want to be successful with your chemical laboratory.
Below is a sample chemical laboratory business plan template that will help you successfully write yours without much stress.
1. industry overview.
Establishments that operates in the Laboratory Testing industry basically perform physical, chemical and other analytical testing for commercial purposes. Such testing may occur in a laboratory or an on-site facility (i.e. where the product is manufactured or developed).
Most results from industry-led tests are checked against government regulations and environmental, industrial and product standards. Please note that this industry does not include medical and veterinary testing labs.
Usually, in an increasingly regulated society, pressure on operators to ensure the safety and quality of their products is higher than ever. A greater number of government safety regulations and consumer lawsuits have led to rigorous testing of manufacturers’ goods prior to sale.
The industry has grown over the past five years, driven by renewed consumer spending and corporate investment in the development of new products. As companies accommodate stricter environmental regulations and invest in new products over the next five years, demand for laboratory testing services is expected to grow.
Statistics has it that in the united states alone, the industry generates over $19 billion annually from more than 10,197 registered and licensed laboratory testing companies scattered all around the United States of America. The industry is responsible for the employment of over 144,658 people.
Experts project the industry to grow at a 1.5 percent annual rate from 2015 to 2018. Bureau Veritas and SGS are the companies with the lion share of the available market in the Laboratory Testing Services industry in the United States of America.
A recent report published by IBISWORLD shows that capital expenditure in the Laboratory Testing Services is low. For every $1.00 spent on labor, an estimated $0.07 is allocated toward capital. The majority of work requires specialized, high-cost equipment to conduct certain types of tests. Additionally, depreciation expenditure is expected to account for 3.8 percent of industry revenue in 2018.
Nonetheless, the industry is heavily labor intensive. Industry employees perform a range of activities, from simple manual tasks and automated experimental procedures to high-tech testing. Since the industry requires a highly skilled labor force, wages are high. Labor costs account for about 50.7 percent of industry revenue in 2018 and have risen substantially over the past five years.
The bottom line is that the laboratory testing services industry is still very much open for new entrants and the competition within the industry is not very stiff. If your laboratory is good, it can gain fair share of the available market in any country or region you intend launching the business.
Nathan Fredrick® Chemical Laboratory, LLC is a licensed laboratory testing company that will be located in an industrial area in Burlington – Vermont.
We have been able to secure a long-term lease agreement for a facility in a strategic location with an option of a long-term renewal on terms and conditions that are favorable to us. The facility has government approval for the kind of business we want to run, the facility is easily accessible.
Nathan Fredrick® Chemical Laboratory will perform physical, chemical and other analytical testing for commercial purposes. Such testing may occur in a laboratory or an on-site facility (i.e. where the product is manufactured or developed). We are also in business to make profits at the same to give our customers value for their money.
We are aware that there are several chemical laboratories scattered all around the United States, which is why we spent time and resources to conduct our feasibility studies and market survey so as to enable us locate the business in an area that can easily accept our services. We ensured that our lab facility is easy to locate and we have mapped out plans to develop a far-reaching network.
Much more than offering highly regulated scientific services, our customer care is going to be second to none. We know that our customers are the reason why we are in business which is why we will go the extra mile to get them satisfied when they patronize our services.
Nathan Fredrick® Chemical Laboratory, LLC will ensure that all our customers are given first class treatment whenever they bring their products for testing in our chemical labs.
We have a CRM software that will enable us manage a one on one relationship with our customers no matter how large they may grow to. We will ensure that we get our customers involved when making some business decisions that will directly or indirectly affect them.
Nathan Fredrick® Chemical Laboratory, LLC is a family business that will be owned and managed by Dr. Nathan Fredrick (PhD) and his immediate family members. Dr. Nathan Fredrick who is the Chief Executive Officer of the Company has PhD in Molecular Science.
He has over 20 years’ experience working in related industry as a senior research director prior to starting Nathan Fredrick® Chemical Laboratory, LLC.
Nathan Fredrick® Chemical Laboratory, LLC is going to run a standard chemical laboratory whose services will not only be accepted in Burlington – Vermont but also throughout the United States of America. We are in the Laboratory testing services industry to make profits and also to give our customers value for their money.
These are some of the services that we will be offering;
Our Business Structure
Nathan Fredrick® Chemical Laboratory, LLC is established with the aim of competing favorably with other leading chemical laboratories in the industry. This is why we will ensure that we put the right structures in place that will support the kind of growth that we have in mind while setting up the business.
We will ensure that we only hire people that are qualified, honest, hardworking, customer centric and are ready to work to help us build a prosperous business that will benefit all our stake holders. As a matter of fact, profit-sharing arrangement will be made available to all our senior management staff and it will be based on their performance for a period of five years or more depending how fast we meet our set target.
In view of that, we have decided to hire qualified and competent hands to occupy the following positions;
Senior Research Fellow/Lab Scientist
Human Resources and Admin Manager
Sales and Marketing Manager
Chief Executive Officer – CEO (Owner):
Accountant/Cashier
Client Service Executive
Laboratory Assistant:
We are quite aware that there are several chemical laboratories in the United States of America which is why we are following the due process of establishing a business. We know that if a proper SWOT analysis is conducted for our business, we will be able to position our business to maximize our strength, leverage on the opportunities that will be available to us, mitigate our risks and be equipped to confront our threats.
Nathan Fredrick® Chemical Laboratory, LLC employed the services of an expert HR and Business Analyst with bias in startup business to help us conduct a thorough SWOT analysis and to help us create a Business model that will help us achieve our business goals and objectives.
This is the summary of the SWOT analysis that was conducted for Nathan Fredrick® Chemical Laboratory, LLC;
Part of what is going to count as positives for Nathan Fredrick® Chemical Laboratory, LLC is the vast experience of our management team. So also, our state of the art chemical laboratory equipment, the wide varieties of laboratory testing services, our large national network and of course our excellent customer service culture will definitely count as a strong strength for the business.
A major weakness that may count against us is the fact that we are a new chemical laboratory in the United States and we don’t have the financial capacity to engage in the kind of publicity that we intend giving the business especially when big names like AbbVie, Amgen Inc., Genentech Inc., Monsanto and Gilead et al are already determining the direction of the market both in the United States and the global market.
The opportunities available to chemical laboratories are enormous and this is anchored on the fact that it is compulsory for any chemical related product and food to undergo testing in the United States. As a result of that, we were able to conduct a thorough market survey and feasibility studies so as to position our business to take advantage of the existing market and also to create our own new market. We know that it is going to require hard work, and we are determined to achieve it.
We are quite aware that just like any other business, some of the major threats that we are likely going to face are economic downturn and unfavorable government policies . Another threat that may likely confront us is the arrival of a new chemical laboratory in same location where ours is located and where our target market exists.
A close study of the trends in the Laboratory testing industry shows that the industry is growing rapidly, with revenue increase over the last five years driven by rising use of chemical based products. Even though the industry has grown, a consolidation trend has emerged as large laboratory testing companies have increasingly targeted industry firms for acquisition, to expand their services portfolios ahead of impending patent expiration.
Sustained spending on research and development, including by the federal government, will benefit the industry going forward, driving growth in revenue generation and of course profit. The fact that there are several fields that need the input of laboratory testing services makes it an industry that is worth paying attention to.
The industry has thrived due to higher government regulation of consumer and food products, government regulation across a range of industries has stimulated demand and aided by the projected expansion of the economy, experts expect industry revenue to grow. Lastly, external factors such as research, development expenditure and consumer spending in the Laboratory Testing industry will impact industry performance.
When it comes to the services offered by chemical laboratories, there is indeed a wide range of available customers. In essence, our target market can’t be restricted to just an industry, but all the industries that manufacture chemical based products and food.
In view of that, we have conducted our market research and we have ideas of what our target market would be expecting from us. Hence our target markets are;
Our competitive advantage
A close study of the laboratory testing industry reveals that the market has become much more intensely competitive over the last half decade. As a matter of fact, you have to be highly creative, customer centric and proactive if you must survive in this industry. We are aware of the stiff competition and we are prepared to compete favorably with other laboratory testing companies in Burlington – Vermont.
Part of what is going to count as competitive advantage for Nathan Fredrick® Chemical Laboratory, LLC is the vast experience of our management team. So also, our state of the art chemical laboratory, the varieties of services we offer, our large and far reaching national network and of course our excellent customer service culture will definitely count as a strong strength for us.
Lastly, our employees will be well taken care of, and their welfare package will be among the best within our category in the laboratory testing services industry, meaning that they will be more than willing to build the business with us and help deliver our set goals and achieve all our aims and objectives. We will also give good working conditions and commissions to freelance sales agents that we will recruit from time to time.
Nathan Fredrick® Chemical Laboratory, LLC is established with the aim of maximizing profits in the laboratory testing services in the United States of America and we are going to ensure that we do all it takes to offer our services to a wide range of customers.
Nathan Fredrick® Chemical Laboratory, LLC will generate income by offering the following services;
One thing is assured, if your laboratory services meet the expected industrial standard and if your laboratory is centrally positioned and easily accessible, you will always attract customers.
We are well positioned to take on the available market in Burlington – Vermont and every city where our services will be offered and we are quite optimistic that we will meet our set target of generating enough income/profits from the first six months of operation and grow the business and our clientele base.
We have been able to examine the laboratory testing services industry, have analyzed our chances in the industry and we have been able to come up with the following sales forecast. Below is the sales projection for Nathan Fredrick® Chemical Laboratory, LLC, it is based on the location of our business and other factors as it relates to small and medium scale chemical laboratory startups in the United States;
N.B : This projection was done based on what is obtainable in the industry and with the assumption that there won’t be any major economic meltdown or a major competitor offering same laboratory testing services as we do within same location. Please note that the above projection might be lower and at the same time it might be higher.
Before choosing a location for Nathan Fredrick® Chemical Laboratory, we conducted a thorough market survey and feasibility studies in order for us to be able to penetrate the available market in our target market locations. We have detailed information and data that we were able to utilize to structure our business to attract the number of customers we want to attract per time.
We hired experts who have good understanding of the industry to help us develop marketing strategies that will help us achieve our business goal of winning a larger percentage of the available market in Burlington – Vermont. In summary, Nathan Fredrick® Chemical Laboratory, LLC will adopt the following sales and marketing approach to attract clients;
Our chemical laboratory is a standard one with a wide range of laboratory testing services that in few years from now will favorably compete with other leading brands in the industry.
Nathan Fredrick® Chemical Laboratory, LLC has a long-term plan of attracting clients all around the United States of America which is why we will deliberately build our brand to be well accepted first in Burlington – Vermont before venturing out.
As a matter of fact, our publicity and advertising strategy is not solely for marketing our services but to also effectively communicate our brand. Here are the platforms we intend leveraging on to promote and advertise Nathan Fredrick® Chemical Laboratory, LLC;
Nathan Fredrick® Chemical Laboratory, LLC will work towards ensuring that all our services are offered at highly competitive prices compared to what is obtainable in the United States of America.
In view of that, our prices will conform to what is obtainable in the industry but will ensure that within the first 6 to 12 months our services are offered a little bit below the average prices of various laboratory testing brands in the United States of America. We have put in place business strategies that will help us run on low profits for a period of 6 months; it is a way of encouraging people to buy into our brand.
The payment policy adopted by Nathan Fredrick® Chemical Laboratory, LLC is all inclusive because we are quite aware that different customers prefer different payment options as it suits them but at the same time, we will ensure that we abide by the financial rules and regulation of the United States of America.
Here are the payment options that Nathan Fredrick® Chemical Laboratory, LLC will make available to her clients;
In view of the above, we have chosen banking platforms that will enable our client make payment for our services without any stress on their part.
Starting a standard chemical laboratory is indeed a capital – intensive business because the amount required in setting up a chemical testing laboratory is not a piecemeal. The bulk of the startup capital will be spent on leasing or acquiring a facility, acquiring license and in purchasing chemical lab machines and equipment.
Aside from that, you are not expected to spend much except for purchase and servicing of distribution trucks, purchasing raw materials, paying of your employees and utility bills.These are the key areas where we will spend our startup capital;
We would need an estimate of $500,000 to successfully set up our chemical laboratory in Burlington – Vermont.
Generating Startup Capital for Nathan Fredrick® Chemical Laboratory, LLC
Nathan Fredrick® Chemical Laboratory, LLC is a family business that is owned and financed by Dr. Nathan Fredrick (PhD) and his immediate family members. They do not intend to welcome any external business partner which is why he has decided to restrict the sourcing of the startup capital to 3 major sources.
N.B: We have been able to generate about $200,000 ( Personal savings $150,000 and soft loan from family members $50,000 ) and we are at the final stages of obtaining a loan facility of $300,000 from our bank. All the papers and documents have been signed and submitted, the loan has been approved and any moment from now our account will be credited with the amount.
The future of any business lies in the number of loyal customers that they have, the capacity and competence of their employees, their investment strategy and the business structure. If all of these factors are missing from a business, then it won’t be too long before the business close shop.
One of our major goals of starting Nathan Fredrick® Chemical Laboratory, LLC is to build a business that will survive off its own cash flow without the need for injecting finance from external sources once the business is officially running.
We know that one of the ways of gaining approval and winning customers over is to offer our services a little bit cheaper than what is obtainable in the market and we are prepared to survive on lower profit margin for a while.
Nathan Fredrick® Chemical Laboratory, LLC will make sure that the right foundation, structures and processes are put in place to ensure that our staff welfare are well taken of. Our company’s corporate culture is designed to drive our business to greater heights and training and retraining of our workforce is at the top burner.
We know that if that is put in place, we will be able to successfully hire and retain the best hands we can get in the industry; they will be more committed to help us build the business of our dreams.
Check List/Milestone
All Formats
10+ laboratory quality assurance plan templates – pdf, doc.
Consumers always want their purchased products and availed services delivered with the highest quality. In turn, business owners, manufacturers, and service providers always aim to meet this high standard as well. This practice is even more important in the health sciences service industry where compliance with predetermined quality assurance plans is in place. You may also see plan templates .
Quality assurance plan template.
Quality assurance project analysis plan.
1. follow a plan format., 2. create an introduction or overview., 3. define your quality objectives., 4. incorporate business branding identities., marine laboratory quality assurance plan.
6. make sure that the quality assurance plan is reviewed and audited., 7. offer problem resolution mechanisms., 8. record everything., water quality assurance project plan example.
More in plan templates.
Clinical laboratory assistant cover letter, clinical laboratory technologist cover letter, laboratory animal caretaker cover letter, medical laboratory scientist cover letter, medical laboratory assistant cover letter.
Word templates, google docs templates, excel templates, powerpoint templates, google sheets templates, google slides templates, pdf templates, publisher templates, psd templates, indesign templates, illustrator templates, pages templates, keynote templates, numbers templates, outlook templates.
IMAGES
VIDEO
COMMENTS
Explore a real-world laboratory business plan example and download a free template with this information to start writing your own business plan.
Learn how to create a medical laboratory business plan with our guide, including key sections and a downloadable PDF template for reference.
Discover the key elements to include in your medical lab business plan. Our guide offers practical advice, templates, and examples to help you write your own.
Download a free laboratory business plan template that includes pre-written examples for every section to help you write your own plan.
Starting a new laboratory is an exciting venture, but it also requires careful planning and strategic thinking. To help medical laboratory owners and entrepreneurs bring their vision to life, ClickUp offers a comprehensive Business Plan Template specifically tailored for laboratory settings.
The first and most critical step in establishing a medical laboratory business is conducting comprehensive research and creating a well-thought-out business plan.
In the competitive and evolving healthcare business market, you can strategize for success. Read the key components of any successful laboratory business plan.
Get Growthink's Medical Lab business plan template & step-by-step instructions to quickly & easily create your Medical Lab business plan.
Download your Medical Laboratory Business Plan Template in MS Word (.docx). Everything you need to plan, manage, finance, and grow your business.
Get step-by-step guidance with our medical lab business plan template to start and grow your medical lab business successfully.
Here is a free business plan sample for a medical analysis laboratory. January 29, 2024. Embarking on the journey to open a medical analysis laboratory can be both exciting and daunting. In the following paragraphs, we will present to you a comprehensive business plan template tailored for a medical analysis laboratory.
How To Use Business Plan Template for Laboratory Technicians. If you're a laboratory technician looking to create a comprehensive business plan, follow these five steps using the Business Plan Template in ClickUp: 1. Define your laboratory's mission and vision. Start by clearly defining the mission and vision of your laboratory.
Need to write a convincing business plan for your medical laboratory fast? Discover which tool to use and what to write in our complete guide.
Creating a lab requires detailed planning and careful execution. For a strong beginning, read this step-by-step guide to starting your own laboratory business.
In this sample business plan for a medical laboratory we have explained how Smith successfully started and run her business. It can serve as an example for you if you are looking for the best medical business plan template to follow for your own startup.
Explore a real-world chemical laboratory business plan example and download a free template with this information to start writing your own business plan.
Medical Laboratory Business Plan Template Download this Medical Laboratory Business Plan Template Design in Word, Google Docs, Apple Pages Format. Easily Editable, Printable, Downloadable.
Okay, so we have considered all the requirements for starting a medical lab & diagnostics center. We also took it further by analyzing and drafting a sample diagnostics center business marketing plan template backed up by actionable guerrilla marketing ideas for diagnostics centers. So let's proceed to the business planning section.
MEDICAL LABORATORY BUSINESS PLAN SAMPLE To establish a successful medical laboratory business, everything regarding its structure must be well planned. Your business plan is basically about charting a path which the healthcare business is supposed to follow.
Are you about starting a chemical laboratory? If YES, here is a complete sample chemical laboratory business plan template & feasibility report you can use for FREE.
Upmetrics' step-by-step instructions, prompts, and the library of 400+ sample business plans will guide you through each section of your plan as a business mentor. 1. Executive Summary. An executive summary is the first section of the business plan intended to provide an overview of the whole business plan.
Learn how to use these laboratory quality assurance plan templates and craft the best strategies for your business or for work.